Aligos Therapeutics (ALGS) Enterprise Value (QoQ) (2019 - 2026)
Aligos Therapeutics (ALGS) Enterprise Value (QoQ) (2019 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
| 1 |
Alterity Therapeutics |
788,338.31 Bn |
788,338.28 Bn |
- |
| 2 |
Belite Bio |
56,560.00 Bn |
56,560.00 Bn |
- |
| 3 |
Quantum Biopharma |
17,329.30 Bn |
17,329.30 Bn |
- |
| 4 |
Legend Biotech |
3,341.00 Bn |
3,340.71 Bn |
242.10 Mn |
| 5 |
Akari Therapeutics |
1,727.91 Bn |
1,727.91 Bn |
- |
| 6 |
Evaxion A |
1,536.68 Bn |
1,536.67 Bn |
- |
| 7 |
Psyence Biomedical |
238.34 Bn |
238.33 Bn |
- |
| 8 |
Vertex Pharmaceuticals |
113.42 Bn |
106.17 Bn |
2.59 Bn |
| 9 |
Abivax |
95.45 Bn |
95.45 Bn |
- |
| 10 |
Aligos Therapeutics |
54.72 Mn |
-25.11 Mn |
- |
| Date | Value |
|---|
| Mar 31, 2026 |
-2.55% |
| Dec 31, 2025 |
50.18% |
| Sep 30, 2025 |
-732.40% |
| Jun 30, 2025 |
86.40% |
| Mar 31, 2025 |
-142.38% |
| Dec 31, 2024 |
24.09% |
| Sep 30, 2024 |
20.68% |
| Jun 30, 2024 |
53.02% |
| Mar 31, 2024 |
-48.22% |
| Dec 31, 2023 |
-92.62% |
| Sep 30, 2023 |
22.39% |
| Jun 30, 2023 |
-14.89% |
| Mar 31, 2023 |
2.94% |
| Dec 31, 2022 |
42.75% |
| Sep 30, 2022 |
10.69% |
| Jun 30, 2022 |
-50.15% |
| Mar 31, 2022 |
44.36% |
| Dec 31, 2021 |
20.66% |
| Sep 30, 2021 |
-27.97% |
| Jun 30, 2021 |
11.98% |
